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Abstract Introduction: Fetal brain
injury is an essential cause of life-
long morbidity. Infection appears 
as a cause of brain damage. Apart
from chorioamnionitis, screening 
for infectious diseases must be con-
sidered in pregnancies with a risk 
of congenital infection or cases with
abnormal cerebral ultrasound find-
ings. Discussion: Congenital infec-
tions include most of the major com-
ponents of the TORCH complex:
toxoplasmosis, rubella, cytomegalo-
virus, herpes, and varicella. Seroneg-
ative mothers can develop primary
infection, which carries a risk of ver-
tical transmission. The timing of the
infection is a critical point, because
fetal damage often depends on the
gestational age at which acute mater-
nal infection took place and occurs
more likely in the first half of preg-
nancy. Antenatal ultrasound can de-
tect brain abnormalities, like hydro-
cephalus, periventricular leukomala-
cia, calcifications or hemorrhage.
Maternal serologic tests must be per-
formed to look for an infectious eti-
ology; the most frequent agents are
the components of the TORCH com-
plex. But additional serology must
include parvovirus B19, HIV, and
coxsackieviruses.
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Introduction
Fetal brain injury remains an essential cause of lifelong
morbidity, which impairs quality of life and social inte-
gration, and incurs large health care charges. Cerebral
white matter damage or maldevelopment are events that
can take place during antenatal life. Although in the ma-
jority of cases the cause remains unknown, the different
antenatal factors involved can be identified [3, 13]. An-
tenatal brain anomaly can be caused by genetic diseases,
trauma, malformations, cerebral hypoxic-ischemic
events, exposure to a toxic agent, preterm delivery, intra-
uterine growth retardation, and infection. In most devel-
oped countries, a policy of general screening has been
adopted. This management will offer some information
concerning fetal brain development, and is aimed at de-
tecting major malformations or identifying increased
risks during pregnancy. Tests performed include various
biochemical markers (Pregnancy-associated Plasma Pro-
tein A, HCG, AFP, Estriol), genetic tests, and ultrasono-
graphic evaluation (e.g., nuchal translucency, morpholo-
gy). To evaluate the risk of maternal exposure to infec-
tious agents, serologic tests for cytomegalovirus (CMV),
toxoplasmosis, rubella, and syphilis are generally per-
formed during the first antenatal visit.
In recent years, convincing evidence has been pub-
lished showing a strong link between intrauterine infec-
tion and fetal brain injury [1, 10]. Infection appears to be
a cause of brain damage through the production of fetal
proinflammatory cytokines [7]. In the presence of cho-
rioamnionitis, high levels of cytokines such as interleu-
kin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis
factor-α (TNF-α) can be detected in the amniotic fluid
and umbilical blood. They contribute to white matter in-
jury in the offspring, leading to periventricular leukomal-
acia or other lesions [6]. The elevated cytokine concen-
tration will directly damage the central nervous system,
and increased severity or prolonged in utero exposure to
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first 6 weeks of pregnancy, increasing steadily thereafter
to reach 80% at the end of the third trimester) [9]. The
risk of severe sequelae is highest during the first trimes-
ter whereas severe forms are almost never observed past
the 25th week of pregnancy. Once maternal infection is
diagnosed, treatment with spiramycin must be initiated.
If fetal infection is confirmed, additional treatment with
pyrimethamine and sulfonamide should be proposed.
Screening for an infectious cause of fetal brain
damage
Antenatal ultrasound examination can detect brain ab-
normalities like intraventricular hemorrhage, hydroceph-
alus, porencephalic cysts, hydranencephaly, or intracra-
nial calcifications. When fetal brain damage is demon-
strated, other associated malformations must be looked
for. Ultrasound remains the gold standard in fetal imag-
ing, but computerized tomography (CT) and, especially,
magnetic resonance imaging (MRI) may be useful in in
utero fetal nervous system evaluation. CT scans provide
some useful information for determining the presence of
acute hemorrhage in the late second trimester [4]. With
CT scans, the risk of the potentially adverse effect of ra-
diation is considered negligible. No biologic risks are
known for MRI. It represents, even in the early mid-tri-
mester, a powerful tool for both anatomic imaging and
tissue characterization [5]. MRI is an important adjuvant
method in clarifying complex sonographic findings.
Whereas ultrasound normograms have been estab-
lished for ventricular size throughout the pregnancy, the
definition of enlarged ventricles is difficult and subjec-
tively evaluated. Fetal hydrocephalus is associated with
CNS malformations or other anomalies in about 80% of
cases. Maternal serologic tests must be performed to
look for an infectious etiology. Most common infectious
agents involved are toxoplasmosis, CMV, HSV, and ru-
bella [8], but in rare situations, treponema pallidum or
parainfluenza virus type 3 can induce fetal hydrocepha-
lus. The prognosis is dependent on the severity and dura-
tion of progressive hydrocephalus [9]. Rather than the
degree of the ventricular enlargement, predictive out-
come is largely determined by other associated abnor-
malities. Some experimental in utero surgical procedures
using a ventriculo-amniotic shunt have been attempted,
but the results were not convincing.
Intrauterine infection with a neurotropic agent can be
associated with brain lesions such as periventricular
leukomalacia, intraventricular hemorrhage, or intracrani-
al calcifications [12]. Intracranial calcifications may
present with different shapes and topography, but they
are strongly suggestive of TORCH intrauterine infection
[11]. Meningitis and meningoencephalitis have been as-
sociated with viral infections and cerebral perivascular
calcification can be observed. Additional maternal serol-
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infection may be associated with increased severity of
neurodevelopment abnormalities. Signs and symptoms
of chorioamnionitis must be looked for carefully during
pregnancy, particularly when preterm labor or preterm
premature rupture of membranes occurs. Unfortunately,
the diagnosis of chorioamnionitis is not always clinically
evident and additional tests must be performed (e.g.,
blood test, C-reactive protein, vaginal swab, and eventu-
ally amniotic fluid culture). Any evidence of chorioam-
nionitis requires a quick decision to proceed to delivery.
Apart from chorioamnionitis, screening for infectious
diseases must be considered in two different situations:
pregnancies with a risk of congenital infectious disease
or cases with abnormal ultrasound findings suggesting
an infectious etiology.
Screening for pregnancies with a risk of congenital
infectious disease
Congenital infections, which may damage the fetal brain,
include the major components of the TORCH complex:
toxoplasmosis, rubella, cytomegalovirus, herpes, and va-
ricella zoster virus [8]. Currently, prenatal routine sero-
logical screening for some TORCH infections is per-
formed during the first trimester. Seronegative patients
can develop primary infection, which carries a risk of
vertical transmission. In case of congenital infection, fe-
tal damage often depends on the gestational age at which
acute maternal infection took place. The timing of mater-
nal infection is thus a critical point. IgG avidity tests are
often helpful to exclude primary maternal infection dur-
ing pregnancy since IgG avidity is directly proportional
to the time lapse since the beginning of the maternal in-
fection. Generally, severe fetal damage is more likely to
occur in the first half of pregnancy than during the sec-
ond half. In congenital rubella, for example, maternal in-
fection in the first 12 weeks of gestation leads to congen-
ital rubella syndrome in about 80% of fetuses with a
poor outcome, whereas congenital infection acquired
during the second half of pregnancy carries no risk to the
fetus [8]. Other viruses can cause intrauterine infection
or may be acquired at the end of pregnancy or during de-
livery (e.g., herpes, varicella). Table 1 shows the average
rates of fetal infection and the type of injuries to the ner-
vous system.
Congenital CMV is the most common congenital in-
fectious disease responsible for both developmental de-
lay and sensorineural deafness. Fetal infection occurs in
30–40% of cases of primary maternal infection and 10%
of infected fetuses will develop cytomegalic inclusion
disease. Of the remaining 90% with asymptomatic con-
genital infection, about 10% will show significant long-
term sequelae, e.g., hearing loss. The risk of congenital
toxoplasmosis varies according to the gestational age at
which acute maternal infection occurred (1% during the
ogy testing must include: parvovirus B19, HIV, and en-
teroviruses, especially coxsackieviruses B1 to B5 and
echoviruses.
Summary
In summary, the prevention of maternal infection is im-
portant during the whole pregnancy. Current prenatal
screening includes maternal serology to identify seroneg-
ative mothers and regular ultrasound to detect early signs
of fetal brain damage. The management of seronegative
pregnant women must include adequate counseling,
careful clinical evaluation, and regular screening during
pregnancy. If vaccination is available, it should be per-
formed after delivery (e.g., postpartum rubella vaccina-
tion).
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